PYC Therapeutics | PYC - Ebitda

Stock Price
1.40
Daily Change
-0.02 -1.06%
Monthly
-6.04%
Yearly
19.66%
Q1 Forecast
1.39

PYC Therapeutics reported AUD-22.79M in EBITDA for its fiscal semester ending in December of 2025.





Ebitda Change Date
Avita Medical AUD -9.69M 12.21M Dec/2025
Medical Developments International AUD 1.78M 3.78M Dec/2024
Neuren Pharmaceuticals AUD 11.14M 165.56M Dec/2025
Pacific Edge NZD -13.97M 332K Sep/2024
Paradigm Biopharmaceuticals AUD -5.86M 3.79M Dec/2024
Telix Pharmaceuticals AUD 18.42M 14.82M Dec/2025